Shortage Status

Status

Date Posted

Date Posted (dd-mm-yyyy)

  • VELCADE bortezomib 3.5 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Jun 2025
    View Detail
  • GAPENTIN gabapentin 800 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 26 Apr 2024
  • TRACLEER bosentan 62.5mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2024
    View Detail
  • TRACLEER bosentan 125mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 Dec 2024
    View Detail
  • PROVIVE MCT-LCT 1% propofol 1000mg/100mL

    Availability: Reduction in supply until supply is exhausted Deletion from market: 31 May 2024
  • PRALUENT alirocumab (rch) 75mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 14 May 2024
  • PRALUENT alirocumab (rch) 150mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2024
  • GLENMARK MOMETASONE ALCOHOL FREE mometasone furoate 1 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 26 Apr 2024
  • APX-GABAPENTIN gabapentin 800 mg

    Availability: Unavailable Deletion from market: 03 Jun 2024
  • TIH-METFORMIN metformin hydrochloride 850 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 17 May 2024
  • METALYSE tenecteplase (rch) 40mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 02 Sep 2024
  • NUCALA mepolizumab 100 mg

    Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Aug 2024